D.E. Shaw & Co
LUMO

D.E. Shaw & Co’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

D.E. Shaw & Co’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,556
Closed -$910K – 3576
2016
Q1 		$910K Buy
5,556
+3,334
+150% +$676K ﹤0.01% 2413
2015
Q4 		$728K Buy
+2,222
New +$723K ﹤0.01% 2852

Other funds holding LUMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co's LUMO Position: Q2 2018 in Review

D.E. Shaw & Co sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 4,687 shares — an estimated $306K sold.

D.E. Shaw & Co first reported a position in LUMO in Q4 2013 and held it in 16 quarters. The position peaked at $4.49M in Q1 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

  • D.E. Shaw & Co reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,687 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $306K.
  • D.E. Shaw & Co first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 16 quarters.
  • D.E. Shaw & Co's Lumos Pharma, Inc. Common Stock position peaked at $4.49M in Q1 2017.
  • 106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.